© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
September 09, 2021
Novavax Incorporation announced on Monday that its combined flu and COVID-19 vaccine elicited working antibodies against the viruses in a preclinical study.
August 11, 2021
Although COVID-19 safety measures helped squash the number of influenza cases last season, pharmacists are revving up vaccination programs and testing.
June 04, 2021
A study highlighted at the 2021 ASCO Annual Meeting explored whether patients who received an influenza vaccine were at increased risk for immune-related adverse events from single-agent immune checkpoint inhibitors.
May 25, 2021
In a session from the PDS 2021 Virtual Super-Conference, experts discussed how POC testing capabilities enhance patient services and address antimicrobial resistance.
March 24, 2021
A recent study looked at the role of the influenza vaccine in COVID-19 susceptibility and severity
February 11, 2021
Preventive efforts, renewed interest in vaccinations drive milder flu season.
February 04, 2021
Peramivir injection (Rapivab; BioCryst) is approved for use in patients aged 6 months and older.
November 23, 2020
Baloxavir marboxil (Xofluza; Genentech) is the first single-dose influenza medicine approved for post-exposure prophylaxis.
November 04, 2020
Pharmacies are seeing an increased demand for flu vaccines in the first season that coincides with the coronavirus pandemic.
October 23, 2020
The combined landscape of flu and COVID-19 presents challenges to vaccine uptake.